Pathological lymph node involvement at surgery is a significant predictive factor of recurrence in locally advanced breast cancer treated with concomitant epirubicin-docetaxel neoadjuvant chemotherapy: a cohort study
Gespeichert in:
Verfasser / Beitragende:
[Kazuharu Kai, Nobuyuki Arima, Haruhiko Miyayama, Yutaka Yamamoto, Hirotaka Iwase, Reiki Nishimura]
Ort, Verlag, Jahr:
2009
Enthalten in:
Breast Cancer, 16/1(2009-01-01), 42-48
Format:
Artikel (online)
Online Zugang: